Join us?

We are actively looking for candidates who are self-motivated, passionate about science and medicine, and have a solid background in the cardiopulmonary biology and/or bioinformatic analysis with a good publication record. Prior experience in either 1) iPSC differentiation and organoid generation, vascular biology and pathobiology, gene editing, genomics/epigenetics, and animal models for cardiopulmonary diseases; or 2) single cell RNA/ATAC seq analysis, spatial transcriptomics, 3D fluid dynamics simulation, and machine learning will be preferred. Candidates must have (or expect to receive) a PhD, MD, or MD/PhD degree.

To apply, please send a single email containing you CV, a short statement describing your qualifications for this position and research interests, as well as contact information for three references to Dr. Mingxia Gu at: mingxia.gu@cchmc.org

Guラボの包括的な目標は、先天性心疾患および肺欠損のある患者の心臓、肺、血管系の再生のための新しい治療法を開発することです。この目標に向けて、Guラボは、患者由来の幹細胞(iPSC)を使用して、 応用および学際的な研究を行っています。iPSC、血管および肺のオルガノイド、動物モデルを用いて、Single cell RNA/ATAC シーケンス、Spatial Transcriptomics、および疾患モデリングとハイスループット薬物スクリーニングのための機械学習を行なっています。

Guラボは現在、意欲的なポスドク研究員と学生を研究チームに採用しています。もしご興味のある方は、添付の資料をご参考にしていただき、Mingxia Gu (mingxia.gu@cchmc.org)さんまでご連絡をお願い致します。

Support us?

Conventional research grant has its limitation in supporting high risk, high reward programs which may lead to major breakthrough in biomedical science. We truly appreciate any financial and infrastructural support for high risk, high reward research projects currently at the Gu Lab.

We are also interested in collaborating with pharmaceutical and biotech companies in testing candidate drugs in our human iPSC/organoid system in a high-throughput and patient-specific manner.